chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: rashes, rashes got bad, new rashes on the forehead ,face and wrist; muscle soreness on the injection site; she still has the itchiness; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (she still has the itchiness), RASH (rashes, rashes got bad, new rashes on the forehead ,face and wrist) and VACCINATION SITE PAIN (muscle soreness on the injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052B22A, 068H21A and 066H21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She had the worst symptoms for 2 weeks and symptoms lingered for about 2 months) on 31-Dec-2021.   On 12-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. In 2022, the patient experienced PRURITUS (she still has the itchiness). On 23-Aug-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (muscle soreness on the injection site). On 30-Aug-2022, the patient experienced RASH (rashes, rashes got bad, new rashes on the forehead ,face and wrist). The patient was treated with PREDNISONE for Allergic reaction, at a dose of 20 milligram once a day and IBUPROFEN for Allergic reaction, at a dose of 1-2 pills. On 26-Aug-2022, VACCINATION SITE PAIN (muscle soreness on the injection site) had resolved. At the time of the report, PRURITUS (she still has the itchiness) and RASH (rashes, rashes got bad, new rashes on the forehead ,face and wrist) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Dec-2021, SARS-CoV-2 test: (Positive) Positive.         Patient height reported as 5. No other vaccines was given within 1 month prior to Moderna COVID-19 vaccine. No concomitant medications was reported. Patient did not experienced a similar event in the past. Patient had new rashes appeared on her forehead, face and wrist on 1-Sep-2022. It was reported that patient will see a specialist for the rashes. Patient had gone to emergency room on 31-Aug-2022. Patient was given steroid for her allergic reaction.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: On 08/31/2022, FDA approved the bivalent booster vaccine. Moderna monovalent is not authorized for booster, outside of clinical guidance.
Age: 14.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Anxiety, Chills, Dizziness, Exercise tolerance decreased, Fatigue
Clinical narrative: Within a week or two of receiving the first vaccine, patient developed low grade fever of 100.0 to 101.0 that was unceasing for months afterwards. She developed fatigue and was very sleepy, along with a feeling of light-headedness.  After the second injection, the dizziness became worse, the fatigue increased, and new symptoms began. She began having sweats and chills, a racing heart, increased anxiety, exercise intolerance, dizziness, and nausea.
Age: 14.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Hyperhidrosis, Laboratory test, Nausea, Palpitations, Pyrexia
Clinical narrative: Within a week or two of receiving the first vaccine, patient developed low grade fever of 100.0 to 101.0 that was unceasing for months afterwards. She developed fatigue and was very sleepy, along with a feeling of light-headedness.  After the second injection, the dizziness became worse, the fatigue increased, and new symptoms began. She began having sweats and chills, a racing heart, increased anxiety, exercise intolerance, dizziness, and nausea.
Age: 14.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Somnolence
Clinical narrative: Within a week or two of receiving the first vaccine, patient developed low grade fever of 100.0 to 101.0 that was unceasing for months afterwards. She developed fatigue and was very sleepy, along with a feeling of light-headedness.  After the second injection, the dizziness became worse, the fatigue increased, and new symptoms began. She began having sweats and chills, a racing heart, increased anxiety, exercise intolerance, dizziness, and nausea.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests abnormal, Audiogram abnormal, Computerised tomogram head, Conductive deafness, Deafness bilateral
Clinical narrative: Within 3 hours of receiving my first COVID pfizer vaccine on 10/2/21, I developed ear pain, bilaterally, greater in my left ear. I also at this time had sudden onset of hearing loss, bilateral ears. This has since progressively worsened with passage of time.    Treatment listed below in item 19
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear pain, Sudden hearing loss, Superior semicircular canal dehiscence, Tympanometry abnormal
Clinical narrative: Within 3 hours of receiving my first COVID pfizer vaccine on 10/2/21, I developed ear pain, bilaterally, greater in my left ear. I also at this time had sudden onset of hearing loss, bilateral ears. This has since progressively worsened with passage of time.    Treatment listed below in item 19
Age: 56.0
Sex: M
Vaccine: UNK
Symptoms: Extra dose administered, Incorrect product formulation administered
Clinical narrative: on 08/31/2022 FDA AUTHORIZED NEW BIVALENT COVID VACCINE THEREFORE MONOVALENT IS NO LONGER AUTHORIZED AS BOOSTER . PT RECEIVED THE 4TH DOSE AS ERROR
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: FDA authorized bivalent booster on 08/31/2022. Patient received the 4th dose in error since monovalent is out of clinical guidance.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: FDA AUTHORIZED  BIVALENT BOOSTER ON 08/31/2022 PT RECEIVED THE 4TH DOSE AS ERROR SINCE MONOVALEN IS OUT OF CLINICAL
Age: 63.0
Sex: M
Vaccine: UNK
Symptoms: Arthralgia, Back pain, Headache, Influenza like illness, Pain
Clinical narrative: Flu-like symptoms ... achiness all over my body (particularly in my lower back and joints), 100 degree temperature, moderately severe headache. I took two 500mg Extra Strength Tylenol caplets this afternoon, but it didn't help much, so I plan to try Advil this evening before I go to bed. This is basically the same way I felt after getting the first dose in April.
Age: 63.0
Sex: M
Vaccine: UNK
Symptoms: Vaccine positive rechallenge
Clinical narrative: Flu-like symptoms ... achiness all over my body (particularly in my lower back and joints), 100 degree temperature, moderately severe headache. I took two 500mg Extra Strength Tylenol caplets this afternoon, but it didn't help much, so I plan to try Advil this evening before I go to bed. This is basically the same way I felt after getting the first dose in April.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: ADAMTS13 activity assay, Cerebral haemorrhage, Confusional state, Contusion, Fatigue
Clinical narrative: TTP-Thrombotic Thrombocytopenia Purpura-Confusion, bruising, renal, extreme tiredness, brain bleed, platelet count below 30k.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Laboratory test, Metabolic function test, Platelet count decreased, Renal disorder
Clinical narrative: TTP-Thrombotic Thrombocytopenia Purpura-Confusion, bruising, renal, extreme tiredness, brain bleed, platelet count below 30k.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombotic thrombocytopenic purpura
Clinical narrative: TTP-Thrombotic Thrombocytopenia Purpura-Confusion, bruising, renal, extreme tiredness, brain bleed, platelet count below 30k.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in arm, hands and fingers
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted twice.   COVID breakthrough infection
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injected limb mobility decreased, Magnetic resonance imaging, Muscle mass
Clinical narrative: Loss of range of motion in left arm
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, Blood triglycerides, Diabetes mellitus, Glycosylated haemoglobin increased, Hypoaesthesia
Clinical narrative: i went to see a cardiologist about my symptoms of tingling and numbness in my  legs, arms, and the right side of my face ion June 24, 2022. He took blood tests and x-rays of my back. My heart  was normal, but he said my symptoms were due to sciatica. He also said my A1c was high and that I had diabetes.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Sciatica, Spinal X-ray
Clinical narrative: i went to see a cardiologist about my symptoms of tingling and numbness in my  legs, arms, and the right side of my face ion June 24, 2022. He took blood tests and x-rays of my back. My heart  was normal, but he said my symptoms were due to sciatica. He also said my A1c was high and that I had diabetes.
Age: 1.42
Sex: F
Vaccine: DTAP, HEPA, IPV
Symptoms: Product preparation issue
Clinical narrative: On Friday, 8/26/22 pharmacist was trying to verify remaining IPOL doses in multidose vial, due to miscount in system. Inserted sterile syringe into vial, drew up remaining 1.5mL vaccine into syringe and returned vaccine to vial without removing syringe from vial, process took approximately 30 seconds to a minute. Vial was returned to stock.  During the two days, Monday and Tuesday, it took to contact the vaccine program to discuss missing dose from inventory, a dose was given to the above patient on Monday 8/29/22. Vaccine program recommend contacting the manufacture to see if measuring remaining vaccine counted as a pre-drawn dose.  Sanofi determined that this would be considered a pre-drawn dose, once vaccine is drawn into a syringe it is considered prepared or "activated". Pediatric team physician was informed of vaccine error and patient will be contacted to be revaccinated per program recommendation. Pharmacist did not realize this would be considered a pre-drawn dose, as there is usually a small amount of vaccine exchanged between the vial and the syringe when drawing each dose from a multidose vial, either due to the provider pulling past the dose then coming back to the exact dose or by trying to get rid of air bubbles by injecting them back into the vial and pulling the remaining dose. Syringe contained no vaccine when remove from the vial and no vaccine was stored in the syringe.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute kidney injury, Aspartate aminotransferase increased, C-reactive protein increased, COVID-19
Clinical narrative: Patient developed symptoms of MISC on 8/2/22; fevers began on 8/3/22 with a Tmax of 40.6 degrees Celsius.  Over the course of illness, symptoms and complications included fevers, acute kidney injury, cough, chest pain, thrombocytopenia, abdominal pain, diarrhea, elevated liver enzymes, rash, mucocutaneous lesions/conjunctivitis, headache, and myalgias. Abnormal labs included elevated CRP, decreased platelets, and elevated AST. ECHO studies showed a coronary artery aneurysm and mitral regurgitation. Patient was admitted to the hospital on 8/7/22 and treated with IVIG, infliximab, and aspirin; he was discharged on 8/10/22.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Conjunctivitis, Coronary artery aneurysm, Cough, Diarrhoea
Clinical narrative: Patient developed symptoms of MISC on 8/2/22; fevers began on 8/3/22 with a Tmax of 40.6 degrees Celsius.  Over the course of illness, symptoms and complications included fevers, acute kidney injury, cough, chest pain, thrombocytopenia, abdominal pain, diarrhea, elevated liver enzymes, rash, mucocutaneous lesions/conjunctivitis, headache, and myalgias. Abnormal labs included elevated CRP, decreased platelets, and elevated AST. ECHO studies showed a coronary artery aneurysm and mitral regurgitation. Patient was admitted to the hospital on 8/7/22 and treated with IVIG, infliximab, and aspirin; he was discharged on 8/10/22.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Headache, Hepatic enzyme increased, Immunoglobulin therapy, Mitral valve incompetence
Clinical narrative: Patient developed symptoms of MISC on 8/2/22; fevers began on 8/3/22 with a Tmax of 40.6 degrees Celsius.  Over the course of illness, symptoms and complications included fevers, acute kidney injury, cough, chest pain, thrombocytopenia, abdominal pain, diarrhea, elevated liver enzymes, rash, mucocutaneous lesions/conjunctivitis, headache, and myalgias. Abnormal labs included elevated CRP, decreased platelets, and elevated AST. ECHO studies showed a coronary artery aneurysm and mitral regurgitation. Patient was admitted to the hospital on 8/7/22 and treated with IVIG, infliximab, and aspirin; he was discharged on 8/10/22.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Mucocutaneous ulceration, Multisystem inflammatory syndrome in children, Myalgia, Platelet count decreased, Pyrexia
Clinical narrative: Patient developed symptoms of MISC on 8/2/22; fevers began on 8/3/22 with a Tmax of 40.6 degrees Celsius.  Over the course of illness, symptoms and complications included fevers, acute kidney injury, cough, chest pain, thrombocytopenia, abdominal pain, diarrhea, elevated liver enzymes, rash, mucocutaneous lesions/conjunctivitis, headache, and myalgias. Abnormal labs included elevated CRP, decreased platelets, and elevated AST. ECHO studies showed a coronary artery aneurysm and mitral regurgitation. Patient was admitted to the hospital on 8/7/22 and treated with IVIG, infliximab, and aspirin; he was discharged on 8/10/22.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test positive, Thrombocytopenia
Clinical narrative: Patient developed symptoms of MISC on 8/2/22; fevers began on 8/3/22 with a Tmax of 40.6 degrees Celsius.  Over the course of illness, symptoms and complications included fevers, acute kidney injury, cough, chest pain, thrombocytopenia, abdominal pain, diarrhea, elevated liver enzymes, rash, mucocutaneous lesions/conjunctivitis, headache, and myalgias. Abnormal labs included elevated CRP, decreased platelets, and elevated AST. ECHO studies showed a coronary artery aneurysm and mitral regurgitation. Patient was admitted to the hospital on 8/7/22 and treated with IVIG, infliximab, and aspirin; he was discharged on 8/10/22.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted once.   COVID breakthrough infection
Age: 29.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site erythema, Injection site pustule, Injection site swelling, Injection site vesicles
Clinical narrative: Have a small pus filler blister at injection site . Around blister is red swelling and mark.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Menstrual disorder, Postmenopausal haemorrhage
Clinical narrative: Menstrual cycle restarted. I am in menopause. Also having issues in my lower digestive tract.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac stress test, Chest pain, Dyspnoea, Electrocardiogram, Mitral valve incompetence
Clinical narrative: Mitral Valve Regurgitation confirmed by (listed below). Sought cardiologist appointment after experiencing non-stop left chest pain over the heart. This has never stopped since.   Since my first vaccine I've developed chronic shortness of breath, phlemmy and productive cough, and sharp chest pain.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough
Clinical narrative: Mitral Valve Regurgitation confirmed by (listed below). Sought cardiologist appointment after experiencing non-stop left chest pain over the heart. This has never stopped since.   Since my first vaccine I've developed chronic shortness of breath, phlemmy and productive cough, and sharp chest pain.
Age: 35.0
Sex: F
Vaccine: FLUA4
Symptoms: Exposure during pregnancy, Muscle spasms
Clinical narrative: I am just shy of 10 weeks pregnant. I got the flu shot yesterday morning (not sure which kind), and since about 8pm yesterday, I have had bad cramping.  I have not experienced such bad cramps before when pregnant. I have no idea if it is related to the shot, but they started later that evening and have not slowed down yet. My EDD is 4/3/23.
Age: 20.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: My right arm about 5 inches spanning horizontal is hard, is red, and hot, has progressively gotten bigger since Saturday, its about 4 inches by 5 inches affected area
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anaemia macrocytic, Angiogram, Body temperature increased
Clinical narrative: Narrative: Pt presented to ED on 8/21/2022 at 2245 with c/o productive cough x 3-4 days and SOB, occurring over past day. Pt reports COVID exposure through family friend. Pt admitted with primary diagnosis of: Acute COVID 19 infection Acute on chronic hypoxic respiratory failure AKI on stage IIIb CKD RUE hematoma - resolving Pt hospitalized 8/22/22 - 8/26/22. ADDITIONAL DIAGNOSES: Type II DM HTN HLD Chronic hypoxic respiratory failure on 4 liters 02 due COPD Chronic CHF due diastolic dysfunction Stage IIIb CKD ETOH dependence Leukocytoclastic vasculitis Macrocytic anemia/pancytopenia Chronic Constipation: h/o Tubular Adenoma HOSPITAL COURSE: Patient is a 79 yo gentleman with Stage IIIb CKD, Chronic CHF due to diastolic dysfunction,chronic hypoxic respiratory failure due to COPD, Type II DM, parosymal afib/aflutter, alcohol dependence who was admitted on 8/21/22 with acute COVID 19 pneumonia. He was admitted to the medical floor on airborne precautions and started on decadron and remdesivir. There was concern for PE given hypoxia, COVID and indeterminate V/Q (unable to obtain CTA due to AKI on admission). However the patient could not anticoagulation due to RUE hematoma at blood pressure cuff site. BLE US were negative for DVT. Hypoxia resolved.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Constipation, Cutaneous vasculitis, Dyspnoea
Clinical narrative: Narrative: Pt presented to ED on 8/21/2022 at 2245 with c/o productive cough x 3-4 days and SOB, occurring over past day. Pt reports COVID exposure through family friend. Pt admitted with primary diagnosis of: Acute COVID 19 infection Acute on chronic hypoxic respiratory failure AKI on stage IIIb CKD RUE hematoma - resolving Pt hospitalized 8/22/22 - 8/26/22. ADDITIONAL DIAGNOSES: Type II DM HTN HLD Chronic hypoxic respiratory failure on 4 liters 02 due COPD Chronic CHF due diastolic dysfunction Stage IIIb CKD ETOH dependence Leukocytoclastic vasculitis Macrocytic anemia/pancytopenia Chronic Constipation: h/o Tubular Adenoma HOSPITAL COURSE: Patient is a 79 yo gentleman with Stage IIIb CKD, Chronic CHF due to diastolic dysfunction,chronic hypoxic respiratory failure due to COPD, Type II DM, parosymal afib/aflutter, alcohol dependence who was admitted on 8/21/22 with acute COVID 19 pneumonia. He was admitted to the medical floor on airborne precautions and started on decadron and remdesivir. There was concern for PE given hypoxia, COVID and indeterminate V/Q (unable to obtain CTA due to AKI on admission). However the patient could not anticoagulation due to RUE hematoma at blood pressure cuff site. BLE US were negative for DVT. Hypoxia resolved.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Haematoma, Hyperlipidaemia, Hypertension, Hypoxia
Clinical narrative: Narrative: Pt presented to ED on 8/21/2022 at 2245 with c/o productive cough x 3-4 days and SOB, occurring over past day. Pt reports COVID exposure through family friend. Pt admitted with primary diagnosis of: Acute COVID 19 infection Acute on chronic hypoxic respiratory failure AKI on stage IIIb CKD RUE hematoma - resolving Pt hospitalized 8/22/22 - 8/26/22. ADDITIONAL DIAGNOSES: Type II DM HTN HLD Chronic hypoxic respiratory failure on 4 liters 02 due COPD Chronic CHF due diastolic dysfunction Stage IIIb CKD ETOH dependence Leukocytoclastic vasculitis Macrocytic anemia/pancytopenia Chronic Constipation: h/o Tubular Adenoma HOSPITAL COURSE: Patient is a 79 yo gentleman with Stage IIIb CKD, Chronic CHF due to diastolic dysfunction,chronic hypoxic respiratory failure due to COPD, Type II DM, parosymal afib/aflutter, alcohol dependence who was admitted on 8/21/22 with acute COVID 19 pneumonia. He was admitted to the medical floor on airborne precautions and started on decadron and remdesivir. There was concern for PE given hypoxia, COVID and indeterminate V/Q (unable to obtain CTA due to AKI on admission). However the patient could not anticoagulation due to RUE hematoma at blood pressure cuff site. BLE US were negative for DVT. Hypoxia resolved.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pancytopenia, Productive cough, SARS-CoV-2 test positive, Ultrasound Doppler normal, Ventilation/perfusion scan
Clinical narrative: Narrative: Pt presented to ED on 8/21/2022 at 2245 with c/o productive cough x 3-4 days and SOB, occurring over past day. Pt reports COVID exposure through family friend. Pt admitted with primary diagnosis of: Acute COVID 19 infection Acute on chronic hypoxic respiratory failure AKI on stage IIIb CKD RUE hematoma - resolving Pt hospitalized 8/22/22 - 8/26/22. ADDITIONAL DIAGNOSES: Type II DM HTN HLD Chronic hypoxic respiratory failure on 4 liters 02 due COPD Chronic CHF due diastolic dysfunction Stage IIIb CKD ETOH dependence Leukocytoclastic vasculitis Macrocytic anemia/pancytopenia Chronic Constipation: h/o Tubular Adenoma HOSPITAL COURSE: Patient is a 79 yo gentleman with Stage IIIb CKD, Chronic CHF due to diastolic dysfunction,chronic hypoxic respiratory failure due to COPD, Type II DM, parosymal afib/aflutter, alcohol dependence who was admitted on 8/21/22 with acute COVID 19 pneumonia. He was admitted to the medical floor on airborne precautions and started on decadron and remdesivir. There was concern for PE given hypoxia, COVID and indeterminate V/Q (unable to obtain CTA due to AKI on admission). However the patient could not anticoagulation due to RUE hematoma at blood pressure cuff site. BLE US were negative for DVT. Hypoxia resolved.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Laboratory test normal, SARS-CoV-2 test
Clinical narrative: Narrative:  A 68yo female who presented to Emergency Department on April 6, 2022 with complaints of worsening SOB and Chest tightness. She is homeless, wanted to establish care and secure housing. The patient communicated having her belongings stolen including her O2 tank. ED NP assessment /plan included Lab, EKG and Covid test, placed on cardiac and pulse ox monitoring. Lab results were unremarkable but was found to be Covid -ve. She has documented multiple medication allergies including Covid vaccine allergy. Patient got admitted to Medicine Unit. The NP in The ADR report documented the patient had historical ADR of Moderna Covid - 19 vaccine induced Respiratory Arrest.. The vaccine administration place was documented as Medical Center in 2019. No other detailed information regarding the vaccine was provided. Documented PMH included T2DM, OSA, HTN, SVT, pAF, CVA, Praplegia, Bowel and Bladder incontinence secondary to spinal cord injury, Power Chair Boud, L, Eye Macuar Degeneration, reported Dxx of Bone Cancer and Lung Cancer ( on 2L oxygen during the day and 3L at night), COPD, PTSD and Homelessness
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Anion gap, Aspartate aminotransferase normal, Basophil count decreased, Basophil percentage, Blood albumin decreased
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium normal, Blood chloride increased, Blood creatinine increased
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood urea increased, Carbon dioxide normal
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Chest X-ray normal, Electrocardiogram abnormal, Eosinophil count decreased, Eosinophil percentage decreased, Glomerular filtration rate decreased
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Granulocyte count, Granulocyte percentage, Haematocrit decreased, Haemoglobin decreased, Laboratory test
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Lymphocyte count decreased, Lymphocyte percentage decreased, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin normal, Mean cell volume normal
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Mean platelet volume normal, Monocyte count normal, Monocyte percentage, Platelet count normal, Presyncope
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Protein total normal, Red blood cell count decreased, Red cell distribution width normal, Sinus bradycardia, Troponin I
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Unresponsive to stimuli, White blood cell count normal
Clinical narrative: Narrative:  6/22/2022 Pt had primary care appt. today, during which patient became unresponsive to sternal rub shortly after receiving Tdap vaccination. likely vasovagal response however will document for future vaccinations. Labs have returned and the only significant abnormality is the hemoglobin which has dropped just under a point since the last one. Is not significant enough to cause the symptoms today. Provider will request a Holter monitor through cardiology and have the patient follow-up with his PCP. Son agrees Pt is at baseline and agrees with care plan. Patient does have a history of blood clots and he is on apixaban twice a day and son states that he has not missed any doses. Patient has had no tachycardia here or respiratory distress I do not feel a chest CT is indicated today. Pt discharged and cardiology consult placed.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time shortened, Acute kidney injury, Acute respiratory failure, Alanine aminotransferase increased, Allen's test
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anion gap, Anticoagulant therapy, Aspartate aminotransferase increased, Atrial flutter
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Bacterial test positive, Basophil count normal, Basophil percentage decreased, Bilirubin urine, Blood albumin decreased
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase increased, Blood bicarbonate decreased, Blood bilirubin normal, Blood calcium decreased, Blood chloride normal
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase normal, Blood creatinine increased, Blood ethanol normal, Blood gases
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood lactic acid, Blood magnesium increased, Blood pH normal, Blood phosphorus
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium increased, Blood sodium decreased, Blood urea increased, Blood urine present, Body temperature increased
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Carbon dioxide decreased, Cardiac monitoring, Cellulitis
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chromaturia, Cough, Cyanosis, Decreased appetite, Diarrhoea
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.